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Submitted 13 September 2010; accepted 13 September 2010 The current issue of the European Journal of Vascular and 
Endovascular Surgery publishes, for the ﬁrst time, the 
results of the Comparison of Surveillance versus Aortic 
Endografting for Small Aneurysm Repair (CAESAR) Trial. 
This multicentre randomised controlled trial investigated 
whether there are survival advantages in performing early 
endovascular aortic aneurysm repair (EVAR) for patients 
with small abdominal aortic aneurysms (AAAs). 
This trial set out to answer an important question, given 
the evidence available at the time of conception. Ouriel et 
al. had showed, using retrospective data including over 700 
patients, that the mid term survival of EVAR patients with 
small aneurysms was signiﬁcantly better than a similar 
cohort of patients with larger aneurysms at the time of 
repair.1 The EUROSTAR registry had also highlighted at this 
time that patients with smaller aneurysms treated with 
endovascular stent grafts are signiﬁcantly less likely to die 
from aneurysm related causes, and overall mortality in 
EVAR patients with aneurysms of less than 5.5 cm in size 
was reduced.2 These ﬁndings have subsequently been 
substantiated in later reports.3 
In the CAESAR trial, no difference in all cause mortality 
was demonstrated between treatment groups. This was 
essentially due to an exceptionally low mortality rate in 
both arms of the trial. Consequently, an excess of three DOI of original article: 10.1016/j.ejvs.2010.08.026. 
* Corresponding author. C.D. Bicknell, MD, FRCS, Vascular 
Secretaries Ofﬁce, Waller Cardiac Building, St Mary’s Hospital, 
Praed St, London W2 1NY, UK. 
1078-5884/$36 ª 2010 European Society for Vascular Surgery. Publishe
doi:10.1016/j.ejvs.2010.09.010 thousand patients would have been needed to prove the 
hypothesis, evident after two years of enrolment. 
The result of this trial essentially mirrors the result of 
two previous trials comparing immediate versus delayed 
open aneurysm repair.4,5 However there are many other 
important considerations with regard to EVAR that are not 
applicable to open repair. One question that must be 
resolved is whether delaying EVAR leads to more patients 
being unsuitable for endovascular repair primarily due to 
reduction in neck length and dilatation. The CAESAR trial 
suggests that 16% of patients previously deemed suitable 
for EVAR were treated with open surgery. There has been 
debate over this question in the literature. Whilst most 
appreciate that suitability for treatment with EVAR does 
change with growth, the size of the aneurysm at which 
suitability for EVAR is determined is contested.6,7 
Another question that remains unanswered is whether 
early EVAR leads to less frequent secondary intervention. 
Certainly the registry data from EUROSTAR2 and the Cleve­
land Clinic1 would suggest this. Proximal and distal type I 
endoleaks occur more commonly during follow up with 
larger aneurysms in both these reports, as does conversion to 
late open repair. These ﬁndings however have not been 
replicated in some studies3 where the rate of secondary 
intervention, migration and endoleak were not increased at 
5 years. The CAESAR trial showed no device migration or loss 
of integrity and a low rate of type I endoleak in those 
repaired early and at a later stage. Whether longer follow up 
is required or this is a direct result of the improvement in 
graft design is impossible to ascertain. d by Elsevier Ltd. All rights reserved. 
27 The CAESAR Trial e Highlighting The Need for Different End Points Lastly, there may be a more signiﬁcant remodeling of 
the aneurysm if treated at an early stage and sac shrinkage 
that may allow a reduction in the frequency of graft 
surveillance compared to those treated later on in the 
course of the disease. Only a long-term trial design with 
detailed imaging analysis will answer this question. 
This trial has shown a remarkable low rate of mortality in 
patients treated with early EVAR and those that are closely 
monitored. It demonstrates that all cause mortality may not 
be the major factor that should be used to assess the beneﬁts 
of early treatment with EVAR and highlights the need to 
search for more appropriate end points in subsequent trials. 
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